Product Program year 2025 Source: CMS Open Payments

S-217622

Drug Infections and Infectious Diseases

Open in the dashboard

General payments

$154,795

86 payments

Research payments

$0

0 payments

Through program year 2025, $154,795 in general payments and $0 in research payments were reported against S-217622 (Infections and Infectious Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $154,795 86

Breakdown

Who paid General payments · program year 2025
  1. Shionogi Inc $154,795 86 payments
Top recipients General payments · program year 2025
  1. Frederick Hayden Infectious Disease · Charlottesville, VA $9,190 6% · 16 payments
  2. Walter Kaufmann Neurodevelopmental Disabilities · Baltimore, MD $4,880 3% · 1 payment
  3. Stefan Gravenstein Geriatric Medicine · Norfolk, VA $4,410 3% · 2 payments
  4. Kelly Gebo Internal Medicine · Baltimore, MD $4,410 3% · 2 payments
  5. Amesh Adalja Infectious Disease · Pittsburgh, PA $3,881 3% · 3 payments

The top 5 of 65 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Infectious Disease Internal Medicine $95,378 62% · 34 practitioners
  2. Internal Medicine $22,230 14% · 11 practitioners
  3. Family Medicine $13,633 9% · 12 practitioners
  4. Neurodevelopmental Disabilities Psychiatry & Neurology $4,880 3% · 1 practitioner
  5. Geriatric Medicine Family Medicine $4,410 3% · 1 practitioner

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $26,255 17% · 11 recipients
  2. Maryland $16,951 11% · 4 recipients
  3. New York $12,153 8% · 6 recipients
  4. Massachusetts $11,080 7% · 4 recipients
  5. Texas $10,185 7% · 4 recipients

The top 5 of 28 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

86 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record